• Needles Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Needles Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Needles Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
High prevalence of chronic diseases worldwide is projected to fuel growth of the needles market
Several factors are associated with increasing adoption of needles worldwide. One of the major
factors is high prevalence of chronic disease across the world, which is propelling demand for
needles. According to the World Health Organization (WHO), in 2017, non-communicable
diseases such as cancer, diabetes, cardiovascular diseases, and lung diseases accounted for
around 70% death worldwide, which was majorly from middle and low income economies.
Furthermore, chronic diseases are expected to account for around 75% of all deaths worldwide
by 2020. Therefore, this is expected to aid in market growth, as needle is an integral part of
chronic disease treatment. For instance, according to Diabetic Atlas by International Diabetes
Federation (IDF), 2017, diabetes affected around 425 million people worldwide. Patients
suffering from diabetes require daily administration of insulin with continuous glucose
monitoring, which in turn is propelling demand for pen needles. Furthermore, the U.S. majorly
invest in treatment of diabetes and cancer, annually. For instance, around US$ 377 Billion are
invested, which account for 52% of the total diabetes expenditure worldwide, according to the
IDF report 2017. Also, according to World Cancer Research Organization, 2014 report, cancer
incidence in the U.S. is one of highest at 328 per 100,000, which is expected to propel growth
of the needles market in this region.
Key players are focusing on strategic mergers and acquisitions and development of innovative
products, in order to enhance their market share. For instance, in September 2017, Becton,
Dickinson and Company introduced BD Ultra-Fine micro pen needle for use with different pen
injection devices, for people with diabetes, in order to reduce accidentally injection of insulin